About ReviR Therapeutics
ReviR Therapeutics is a company based in San Francisco (United States) founded in 2021 by Yang Li.. ReviR Therapeutics has raised $50 million across 3 funding rounds from investors including XtalPi, Tiantu Investment and Lapam Capital. ReviR Therapeutics offers products and services including REVIR Platform. ReviR Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter San Francisco, United States
- Founders Yang Li
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$50 M (USD)
in 3 rounds
-
Latest Funding Round
$4.6 M (USD), Grant
Nov 20, 2025
-
Investors
XtalPi
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ReviR Therapeutics
ReviR Therapeutics offers a comprehensive portfolio of products and services, including REVIR Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for AI-assisted RNA-based drug discovery processes.
Unlock access to complete
Unlock access to complete
Funding Insights of ReviR Therapeutics
ReviR Therapeutics has successfully raised a total of $50M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $4.6 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $4.6M
-
First Round
First Round
(17 Jan 2022)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Grant - ReviR Therapeutics | Valuation | State of California |
|
| Jul, 2024 | Amount | Series A - ReviR Therapeutics | Valuation | Lapam Capital | |
| Jan, 2022 | Amount | Seed - ReviR Therapeutics | Valuation | 5Y Capital , CDH |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ReviR Therapeutics
ReviR Therapeutics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include XtalPi, Tiantu Investment and Lapam Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Private equity and private debt firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on technology and innovation investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ReviR Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ReviR Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Revir Therapeutics Comparisons
Competitors of ReviR Therapeutics
ReviR Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Revir Therapeutics
Frequently Asked Questions about ReviR Therapeutics
When was ReviR Therapeutics founded?
ReviR Therapeutics was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is ReviR Therapeutics located?
ReviR Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is ReviR Therapeutics a funded company?
ReviR Therapeutics is a funded company, having raised a total of $50M across 3 funding rounds to date. The company's 1st funding round was a Seed of $20M, raised on Jan 17, 2022.
What does ReviR Therapeutics do?
ReviR Therapeutics was established in 2021 in San Francisco, United States, within the biotechnology sector. RNA-based medicines are created for cancer, rare genetic disorders, and infectious diseases. Machine learning and advanced RNA methods are applied to support these efforts. Operations center on research and development to address unmet medical needs through targeted therapeutic approaches.
Who are the top competitors of ReviR Therapeutics?
ReviR Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does ReviR Therapeutics offer?
ReviR Therapeutics offers REVIR Platform.
Who are ReviR Therapeutics's investors?
ReviR Therapeutics has 10 investors. Key investors include XtalPi, Tiantu Investment, Lapam Capital, CDH, and 5Y Capital.